Company information
- Ticker
- NRRSF
- Country
- United States
- Sector
- Materials
- Industry
- Gold
Norsemont Mining Business Summary
Norsemont Mining Inc. (NRRSF) is a Canadian-based mineral exploration and development firm specializing in the acquisition and advancement of gold, silver, and copper assets in Chile. The company’s business model is predicated on the systematic de-risking of its 100%-owned flagship Choquelimpie project, a past-producing mine located in the Arica and Parinacota Region. Revenue generation is currently focused on a dual-track development strategy: the near-term processing of existing oxide stockpiles and the long-term expansion of high-grade sulfide and porphyry resources through its Phase 3 and Phase 4 drilling programs. Primary business segments include mineral exploration, metallurgical engineering, and resource estimation. Norsemont competes with junior miners such as Pirate Gold, Cartier Resources, and Greenheart Gold, but maintains a competitive advantage due to its extensive onsite infrastructure, including a 3,000 tonne-per-day mill and a substantial NI 43-101 resource base of approximately 2.74 million gold-equivalent ounces. The company is led by CEO and Chairman Marc Levy, a prominent entrepreneur who previously founded the original Norsemont Mining (acquired by Hudbay Minerals for $520 million) and was a founder of Aurora Cannabis. The executive team was significantly bolstered in early 2026 with the appointments of CFO Charles Ross and Chief Geologist David Flint, a veteran of Freeport-McMoRan and Allied Nevada Gold with over 35 years of exploration expertise. Technical leadership includes Chief Engineer David Laing, whose background spans senior roles at Quintana Resources and Endeavour Financial, and Lead Geologist Roman Flores, who brings 50 years of Chilean mining experience from Codelco and Barrick Gold. Strategic guidance is provided by advisor Paul Matysek, a prolific mining executive with a track record of multi-billion dollar exits, alongside a board featuring Dr. Sergei Diakov and Nikolas Perrault.